Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: A nested cohort study

Journal of the American Academy of Dermatology

Volumn 49, Issue 4, 2003, Pages 644-650

  Nijsten, Tamar E C ^b   Stern, Robert S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK ASSESSMENT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0141867886     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)01587-1     Document Type: Article

References (28)

1. Hansen LA, Sigman CC, Andreola F, Ross SA, Kellof GJ, De Luca LM. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21:1271-9.
2. Stratton SP, Dorr RT, Alberts DS. The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer 2000;36:1292-7.
3. Halliday GM, Ho KKL, Barnetson RSTC. Regulation of the skin immune system by retinoids during carcinogenesis. J Invest Dermatol 1992;99(Suppl):83-6S.
4. McKerrow KJ, Mackie RM, Lesko MJ, Pearson C. The effect of oral retinoid therapy on the normal human immune system. Br J Dermatol 1988;119:313-20.
5. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988;318:1633-7.
6. Kelly JW, Sabto J, Gurr FW, Bruce F. Retinoids to prevent skin cancer in organ transplant recipients [letter]. Lancet 1991;3381-407.
7. Bouwes Bavinck JN, Tieben LM, Van Der Woude FJ, Tegzess AM, Hermans J, ter Schegget J, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal recipients: a double blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
8. Rook AH, Jaworsky C, Nguyen T, Grossman RA, Wolfe JT, Witmer WK, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995;59:714-9.
9. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 2001;140:656-60.
10. Van de Kerkhof PC, De Rooij MJ. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. Br J Dermatol 1997;136:275-8.
11. Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ, et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J Natl Cancer Inst 1992;84:328-32.
12. Levine N, Moon TE, Cartmel B, Bangert JC, Boulanger A, Claudy A, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double blind, controlled trial. Cancer Epidemiol Biomarkers Prev 1997;6:957-61.
13. Lassus A, Geiger JM, Nyblom M, Virronkoski T, Kaartamaa M, Ingervol L. Treatment of severe psoriasis with etretin (Ro 10-1670). Br J Dermatol 1987;117:333-41.
14. Lauharanta J, Juvakoski T, Lassus A. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of a retinoid and PUVA, and PUVA alone in severe psoriasis. Br J Dermatol 1981;104:325-32.
15. Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988;177:218-24.
16. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneaous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
17. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994;73:2759-64.
18. Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA follow-up study. J Natl Cancer Inst 1998;90:1278-84.
19. Lindelof B, Sigugeirsson E, Tegner E, Larko O, Johannesson A, Berne B, et al. PUVA and cancer: a large scale epidemiological study. Lancet 1991;338:91-3.
20. Lever LR, Farr PM. Skin cancer or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994;131:215-9.
21. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, et al. A clinical trial of beta-carotene to prevent basal-cell and squamous cell cancers of the skin: the skin cancer prevention study group. N Engl J Med 1990;323:789-95.
22. Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in physician's health study. Arch Dermatol 2000;136:179-84.
23. Moon TE, Levine N, Cartmel B, Bougert JL, Rodney S, Dong Q, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidemiol Biomarkers Prev 1997;6:949-56.
24. Peck GL, Gross EG, Butkus D, Gross EG, Butkus D, Olsen TG, et al. Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol 1982;6:815-23.
25. Peck GL, DiGiovanna JJ, Sarnoff DS. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988;19:176-85.
26. Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 1989;21:144-5.
27. DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL. Extraspinal tendon and ligament calcification associated with long term therapy with etretinate. N Engl J Med 1986;315:1177-82.
28. Stern RS, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD. The safety of etretinate as long-term therapy for psoriasis: results of the etrinate follow-up study. J Am Acad Dermatol 1995;33:44-52.